{"DataElement":{"publicId":"4616531","version":"1","preferredName":"Neuroblastoma First Specimen Recurrent Disease Tumor To Stroma Ratio Percentage Value","preferredDefinition":"Numeric representation of the percent of tumor versus stroma for first relapse sample.","longName":"4616485v1.0:4616486v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"4616485","version":"1","preferredName":"Neuroblastoma First Specimen Recurrent Disease Malignant Neoplasm To Stroma Ratio","preferredDefinition":"A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation._Preceding all others in time or space or degree._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The return of a disease after a period of remission._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Used as a function word to indicate direction, purpose, or movement._The non-neoplastic connective tissue of an organ._Quotient of quantities of the same kind for different components within the same system.","longName":"2961432v1.0:4616483v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2961432","version":"1","preferredName":"Neuroblastoma","preferredDefinition":"Neuroblastoma is a specific type of neuroblastic tumor which is characterized by the presense of neuroblastic cells forming groups or nests separated by delicate stromal septa without prominent Schwannian stroma. (Adapted from WHO.)","longName":"C3270","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroblastoma","conceptCode":"C3270","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"78A9872E-E000-5A53-E040-BB89AD437199","latestVersionIndicator":"Yes","beginDate":"2009-11-18","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-18","modifiedBy":"ONEDATA","dateModified":"2009-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4616483","version":"1","preferredName":"First Specimen Recurrent Disease Malignant Neoplasm To Stroma Ratio","preferredDefinition":"Preceding all others in time or space or degree.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:The return of a disease after a period of remission.:Uncontrolled growth of abnormal cells with potential for metastatic spread.:Used as a function word to indicate direction, purpose, or movement.:The non-neoplastic connective tissue of an organ.:Quotient of quantities of the same kind for different components within the same system.","longName":"4616483v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stroma","conceptCode":"C67387","definition":"The non-neoplastic connective tissue of an organ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0931BD13-31BC-E676-E050-BB89AD4358B5","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0931BD13-31CD-E676-E050-BB89AD4358B5","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 12/1/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4616486","version":"1","preferredName":"TARGET Percentage Value","preferredDefinition":"A numerical quantity measured or assigned or computed.","longName":"4616486v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"1","format":"%","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2414933","version":"1","preferredName":"Value","preferredDefinition":"A numerical quantity measured or assigned or computed.","longName":"C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"02772734-9BE5-6ADF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-06","modifiedBy":"ONEDATA","dateModified":"2005-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0931BD13-31EB-E676-E050-BB89AD4358B5","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"COOPERM","dateModified":"2015-04-28","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 12/1/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650574","version":"1","longName":"NBL","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Relapse Percent Tumor Vs Stro","type":"Preferred Question Text","description":"Relapse Percent Tumor Vs Stroma","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09340804-9322-9C2A-E050-BB89AD433CA4","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-01","modifiedBy":"COOPERM","dateModified":"2017-02-02","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 12/1/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}